Briacell Therapeutics Corp Stock (BCTX) Forecast
The Briacell Therapeutics Corp (BCTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $26.03, representing a +614.97% increase from the current price of $3.64. The highest analyst price target is $41.53, and the lowest is $10.52.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCTX Price Target
Average 29.44 (+708.74% Upside)
Is Briacell Therapeutics Corp (BCTX) A Buy Now?
Oscillators
Buy: 1 · Sell: 3 · Neutral: 3Summary: Neutral
Moving Averages
Buy: 6 · Sell: 4 · Neutral: 0Summary: Buy
According to our latest analysis, BCTX could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on BCTX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 54.01 indicates that BCTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.88 indicates that BCTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that BCTX is overbought. This suggests that BCTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 33.10 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of 43.58 indicates that BCTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BCTX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Briacell Therapeutics Corp financial reports and earnings history, Briacell Therapeutics Corp (BCTX) stock could reach $54.92 by 2030, $209.33 by 2040 and $581.95 by 2050. See the projected annual prices until 2050 of the Briacell Therapeutics Corp stock below:
- Briacell Therapeutics Corp (BCTX) is expected to reach an average price of $102.57 in 2035, with a high prediction of $126.68 and a low estimate of $103.41. This indicates an +2,718% change from the last recorded price of $3.64.
- Briacell Therapeutics Corp (BCTX) stock is projected to chart a bullish course in 2040, with an average price target of $191.38, representing an +5,158% change from its current level. The forecast ranges from a conservative $180.38 to a sky-high $209.33.
- Our analysts predict Briacell Therapeutics Corp (BCTX) to change +7,643% by 2045, soaring from $276.48 to an average price of $281.85, potentially reaching $385.19. While $276.48 is the low estimate, the potential upside is significant.
- Briacell Therapeutics Corp (BCTX) stock is expected to climb by 2050, reaching an average of $432.61, a +11,785% change from its current level. However, a wide range of estimates exists, with high and low targets of $581.95 and $440.11, respectively, highlighting the market's uncertainty.
Briacell Therapeutics Corp Stock (BCTX) Year by Year Forecast
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2026
The predicted value for Briacell Therapeutics Corp (BCTX) in 2026 is set at an average of $3.66. Estimates vary from a peak of $41.53 to a trough of $2.60, indicating an +0.42% surge from the present price of $3.64.
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Briacell Therapeutics Corp (BCTX) is $27.79, with a high forecast of $54.39 and a low forecast of $4.49. This indicates an +663.32% increase from the last price of $3.64.
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2028
In 2028, Briacell Therapeutics Corp (BCTX) is projected to reach an average price of $11.39, with a high projection of $42.52 and a low estimate of $0.1441. This indicates an +212.82% rise from the last price of $3.64.
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2029
The 2029 price forecast for Briacell Therapeutics Corp Stock (BCTX) is $37.26 on average, with a high prediction of $57.98 and a low estimate of $7.46. This represents an +923.52% increase from the previous price of $3.64.
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2030
Briacell Therapeutics Corp Stock (BCTX) is expected to reach an average price of $46.51 in 2030, with a high forecast of $54.92 and a low forecast of $38.99. This signifies an +1,178% surge from the last price of $3.64.
